On NoticeOn Notice
← Bills

Therapeutic Goods Amendment (Medicines Shortages and Other Measures) Bill 2026

Second Reading
16 November 2026 · 3 days agoExplanatory Memorandum →

Summary

This amendment to the Therapeutic Goods Act tackles medicine shortages in Australia by giving the government faster ways to approve alternative medicines and temporarily adjust supply requirements when stocks run low. When a critical medicine becomes hard to find, the changes let regulators quickly authorise substitutes or modified versions without the usual lengthy approval process, and allow companies to adjust how much they must keep on hand. For patients, this means less risk of running out of essential medications during supply disruptions, while for pharmaceutical companies it provides clearer rules about what flexibility they have when their usual products aren't available.

Bill Progress

Senate

First Reading

Second ReadingCurrent

Committee of the Whole

Third Reading

House of Representatives

First Reading

Second Reading

Consideration in Detail

Third Reading

Royal Assent

Royal Assent

What happens at this stage

The main debate on whether the chamber supports the broad purpose of the bill. Members speak to its overall merits and concerns rather than the fine print. The government outlines its policy intentions; the opposition and crossbench put their case. This is the stage that determines whether the bill proceeds at all.

Next: Consideration in Detail (House) or Committee of the Whole (Senate), where the bill is examined clause by clause